#Japan #Tokyo #Cell Cloud #Diet #Cancer Risk

Understanding the Connection Between Diet and Cancer Risk

In recent years, the awareness surrounding cancer prevention has steadily increased. However, surprisingly, only about 30% of people actively engage in preventive measures against this deadly disease. Many individuals believe they are consuming healthy food yet unknowingly maintain a diet lacking in nutritional balance and variety.

To address this gap, Cell Cloud, based in Shibuya, Tokyo, has released a new guide titled "Understanding Cancer Patients and Non-Patients Through Dietary Habits", which is now available for free. The guide delves into scientifically backed insights on how dietary habits can influence cancer risk and offers practical, actionable strategies for improvement. You can access and download the guide through their official LINE account: Download Here.

What You Can Learn from This Guide

The guide elucidates several critical aspects:

• - Clear Evidence: It discusses the significant disparities in cancer risk associated with different dietary habits, supported by robust evidence.
• - Understanding Fixed Patterns: The mechanism behind the fixation of dietary deviations that may affect cancer risk is thoroughly examined.
• - Practical Changes: Strategies for dietary 'substitution' that can be implemented immediately to enhance health and reduce risk are explored in detail.

Who Should Read This Guide?

This guide is highly beneficial for:

• - Those committed to healthy eating but lacking clear criteria for cancer prevention.
• - Busy executives and professionals wishing to reassess their nutrition to mitigate cancer risk.
• - Individuals eager to gain knowledge about cancer prevention based on scientific evidence.

Chapter Breakdown

The guide includes several informative chapters:

Chapter 1: Why do health-conscious individuals still experience anxiety?

Chapter 2: Unearthing differences among Japanese individuals.

Chapter 3: The distinction is not in quantity but in the fixation of deviations.

Chapter 4: Self-check: Which side are you closer to?

Chapter 5: Transform today by focusing on 'substituting' rather than 'adding'.

Chapter 6: Reflection on whether your eating habits can be explained to your future self.

Chapter 7: An overview of Cell Cloud’s CTC testing.

Addressing Cancer Anxiety and Suffering

Currently, statistics indicate that more than one in two Japanese individuals will develop cancer, with nearly 40% of adults over 40 succumbing to the disease. The fear of cancer comes from its unpredictable nature and the difficulty in early detection, often leading to dire outcomes before individuals realize their condition.

Even those who undergo annual health check-ups may struggle to have a comprehensive screening for all possible cancer risks. Cancer can arise in various locations beyond commonly known areas such as the lungs and stomach. Unfortunately, to obtain thorough screening, patients must undergo additional tests that can be time-consuming and costly.

The primary reason many individuals avoid cancer testing is the lack of time. While there is a strong desire to undergo testing, the barrier to even basic screenings or comprehensive screenings seems insurmountable. Fortunately, easy-to-use testing options have emerged, which only require samples of blood, urine, or saliva. However, results often only provide statistical indications of risk and can lead to uncertainties.

Against this backdrop, Cell Cloud’s Micro CTC testing aims to enhance cancer risk assessment by detecting circulating tumor cells that have entered the bloodstream. This method allows for a much more precise evaluation of cancer risk through just a single blood sample, enabling comprehensive screenings without invasive tests.

For those with limited time, this method is a revolutionary way to identify cancer risk. By reducing uncertainty, we believe that many can alleviate their anxiety surrounding cancer, transforming fear into empowerment through knowledge.

Anxiety such as fearing potential cancer, worrying about reoccurrency, or contemplating the implications of a positive diagnosis can be overwhelming. Eliminating these sources of worry is crucial to reducing the suffering associated with cancer.

Our mission is to ensure that the Micro CTC test becomes accessible to as many people as possible to eradicate the fear and pain associated with cancer.

For more information, visit: Cell Cloud

Company Overview

Name: Cell Cloud Inc.
Founded: April 2022
CEO: Tomoyuki Hamano
Headquarters: 5F, 5-21-7 Sendagaya, Shibuya-ku, Tokyo, 151-0051
Services: Cancer risk assessment using Micro CTC testing
Website: Cell Cloud